LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.88 | 84.90 | 7466 | 7291 | 1.0239 | 1.0074 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.59 | 84.90 | 7130 | 7641 | 0.9330 | 0.9788 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.59 | 84.90 | 7331 | 7641 | 0.9593 | 0.9872 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.59 | 84.90 | 826 | 7641 | 0.1081 | 0.4197 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.59 | 84.90 | 7826 | 7641 | 1.0241 | 1.0073 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 62.29 | 84.90 | 7371 | 7934 | 0.9290 | 0.9776 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 62.29 | 84.90 | 7642 | 7934 | 0.9631 | 0.9886 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 62.29 | 84.90 | 850 | 7934 | 0.1071 | 0.4218 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 62.29 | 84.90 | 8191 | 7934 | 1.0323 | 1.0097 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.99 | 84.90 | 7577 | 8212 | 0.9226 | 0.9757 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.99 | 84.90 | 7953 | 8212 | 0.9684 | 0.9903 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.99 | 84.90 | 936 | 8212 | 0.1140 | 0.4389 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.99 | 84.90 | 8496 | 8212 | 1.0345 | 1.0103 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.70 | 84.90 | 7727 | 8484 | 0.9108 | 0.9721 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.70 | 84.90 | 8213 | 8484 | 0.9680 | 0.9902 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.70 | 84.90 | 1004 | 8484 | 0.1183 | 0.4505 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.70 | 84.90 | 8869 | 8484 | 1.0453 | 1.0134 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.41 | 84.90 | 7887 | 8766 | 0.8997 | 0.9687 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.41 | 84.90 | 8444 | 8766 | 0.9632 | 0.9888 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.41 | 84.90 | 936 | 8766 | 0.1068 | 0.4316 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.41 | 84.90 | 9188 | 8766 | 1.0481 | 1.0141 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.11 | 84.90 | 7827 | 8988 | 0.8708 | 0.9593 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.11 | 84.90 | 8616 | 8988 | 0.9586 | 0.9875 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.11 | 84.90 | 1090 | 8988 | 0.1213 | 0.4615 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.11 | 84.90 | 9479 | 8988 | 1.0546 | 1.0159 | MN20160318_Q02 | K13 |